1,166
Views
9
CrossRef citations to date
0
Altmetric
Research paper

Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis

, & ORCID Icon
Pages 9046-9057 | Received 18 Jul 2021, Accepted 11 Oct 2021, Published online: 28 Oct 2021

Figures & data

Figure 1. LINC01094 expression is up-regulated in BC tissues

(a) With the GEPIA database, box plots were adopted for analyzing LINC01094 expression difference in BC and para-tumorous tissues. (b) Detection via qRT-PCR of LINC01094 expression in 54 cases of BC and para-cancerous tissues. (c) According to GEPIA database, the relationship between LINC01094 expression and the BC patient’s survival was analyzed. *P < 0.05, **P < 0.01 and ***P < 0.001.
Figure 1. LINC01094 expression is up-regulated in BC tissues

Figure 2. LINC01094 has effects on cell proliferation, cell cycle progression and apoptosis

(a) Detection by qRT-PCR of LINC01094 expression in BC cell lines (MCF-7, L6, MDA-MB-231, MCF10CA1a and DU4475) and MCF-10A cells. (b) Detection via qRT-PCR of the transfection efficiency of LINC01094, si-LINC01094-1 and si-LINC01094-2 in MCF-7 and MDA-MB-231 cells. (c,d) BrdU and CCK-8 assays were performed to detect the effects of LINC01094 on MDA-MB-231 and MCF-7 cells’ proliferation. (e,f) The effects of LINC01094 on MDA-MB-231 and MCF-7 cell apoptosis and cell cycle were detected by flow cytometry assay. *P < 0.05, **P < 0.01 and ***P < 0.001
Figure 2. LINC01094 has effects on cell proliferation, cell cycle progression and apoptosis

Figure 3. LINC01094 directly targets miR-340-5p in BC cells

(a) The subcellular location of LINC01094 was assessed via qRT-PCR after nucleocytoplasmic separation. (b) StarBase database predicted the binding site between LIN01094 and miR-340-5p. (c) MCF-7 and MDA-MB-231 cells were co-transfected with MUT LINC01094 or WT LINC01094 reporter with miR-340-5p inhibitors or mimics, respectively; the dual-luciferase reporter gene system was utilized to detect the luciferase activity. (d) RIP assay was employed to verify the binding relationship between LINC01094 and miR-340-5p. E. The effects of LINC01094 overexpression and knockdown on miR-340-5p expression in BC cells were detected via qRT-PCR. F. MiR-340-5p expression in 54 cases of BC and para-cancerous tissues was detected via qRT-PCR. G. Pearson correlation analysis of the correlation between LINC01094 and miR-340-5p expressions in BC tissues. *P < 0.05, **P < 0.01 and ***P < 0.001.
Figure 3. LINC01094 directly targets miR-340-5p in BC cells

Figure 4. LINC01094 up-regulates E2F3 expression via sponging miR-340-5p

(a) StarBase database and TargetScan database were employed for predicting downstream miR-340-5p targets. (b, C) KEGG and GO databases were used to perform a pathway enrichment analysis of the target genes of miR-340-5p. (d) The online database StarBase was applied to predict the binding site of miR-340-5p to E2F3 mRNA 3ʹUTR. E. MUT E2F3 or WT E2F3 luciferase reporter vectors were co-transfected with miR-340-5p inhibitors or mimics into MCF-7 and MDA-MB-231 cells, and then the luciferase activity was detected. (f) Western blot was conducted to detect the regulatory effects of LINC01094 and miR-340-5p on E2F3 expression. (g) E2F3 mRNA expression in 54 pairs of BC tissues and para-cancerous tissues was examined through qRT-PCR. H-I. Pearson correlation analysis of the correlation among LINC01094, E2F3 mRNA and miR-340-5p expressions in BC tissues. *P < 0.05, **P < 0.01 and ***P < 0.001.
Figure 4. LINC01094 up-regulates E2F3 expression via sponging miR-340-5p

Figure 5. The impacts of LINC01094 and miR-340-5p of BC cell proliferation, cycle progression and apoptosis

A. LINC01094 overexpression plasmids, LINC01094 overexpression plasmids + miR-340-5p mimics and LINC01094 overexpressoin plasmids + miR-340-5p mimics + E2F3 overexpression plasmids were into MDA-MB-231 cells, respectively, and si-LINC01094-1, si-LINC01094-1 + miR-340-5p inhibitors and si-LINC01094-1 + miR-340-5p inhibitors + si-E2F3 were transfected into MCF-7 cells, respectively. The transfection efficiency was measured via qRT-PCR. B-C. BrdU and CCK-8 assays were utilized to detect the impacts of LINC01094, miR-340-5p, E2F3 on BC cell proliferation. D-E. Flow cytometry was utilized for detecting the impacts of LINC01094, miR-340-5p and E2F3 on BC cell apoptosis and cycle progression. *P < 0.05, **P < 0.01 and ***P < 0.001.
Figure 5. The impacts of LINC01094 and miR-340-5p of BC cell proliferation, cycle progression and apoptosis

Figure 6. LINC01094 promoted the lung metastasis of MDA-MB-231 cells in vivo.

H&E staining was used to detect the metastatic nodule of the mice, which were injected with MDA-MB-231 cells transfected with LINC01094 overexpression plasmids or control plasmids, and the representative images were shown
Figure 6. LINC01094 promoted the lung metastasis of MDA-MB-231 cells in vivo.

Data availability statement

The data used to support the findings of this study are available from the corresponding author upon request.